Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Tourette syndrome research is shifting focus from tics to mental health. A bibliometric analysis of 2,311 publications from 2001–2025 found a growing emphasis on psychiatric comorbidities like depression, anxiety, and ADHD in Tourette syndrome (TS) research — moving beyond tic control. Crucially, psychiatric symptoms and functional impairment in TS patients didn't consistently align with tic severity, underscoring the need for independent depression assessments.
Research on Tourette syndrome (TS) has been quietly evolving. A new bibliometric analysis of 2,311 publications from 2001 to 2025 reveals a clear trend: scientists are increasingly looking beyond tic control and toward the psychiatric toll the condition takes — particularly depression. Annual publication counts climbed from roughly 30–58 per year in the early 2000s to 146–148 by the mid-2020s, reflecting growing scholarly interest.
The U.S. led global output (31.5% of publications), but countries like Sweden and the UK showed higher international collaboration rates. Key research themes shifted from pharmacologic tic management in earlier years to psychiatric comorbidities, standardized mental health assessments, and quality-of-life outcomes in more recent work.
Key Takeaways:
Why it matters: For clinicians treating TS, these findings are a call to action: assessing and treating depression independently — not just managing tics — may be essential to improving patients' overall functioning and quality of life.